CrownBio Completes Validation of Prostate Cancer Patient-Derived Xenograft (PDX) Models
SAN DIEGO, Sept. 26, 2018 (GLOBE NEWSWIRE) -- Crown Bioscience, a global drug discovery and development services company providing translational platforms to advance oncology, inflammation, cardiovascular and metabolic disease research, has announced the …